Abstract
Tumor Therapy In article number 2110094, Jianxun Ding and co-workers develop a versatile polymer, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-poly(ethylene glycol)-alendronate (DPA), for osteosarcoma blockade therapy. DPA not only initiates biomineralization in the peripheral tissue of tumors after insertion into the cytomembrane, but also alleviates bone destruction efficiently, both of which significantly inhibit the growth and lung metastasis of osteosarcoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
